/Companies

Axon Therapeutics

San Diego, US · Founded 2022 · Delaware corporation

Find your way into Axon Therapeutics

Sign up to see every warm intro you have to Axon Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Axon Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DC
David c DodickNamed on SEC filing
PR
Pierre RiviereNamed on SEC filing
FP
Frank PorrecaNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2022

▶$5MraisedAug 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David c DodickDirector
  • Pierre RiviereExecutive Officer, Director
  • Frank PorrecaDirector
Offering amount
$5M
Amount sold
$5M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Axon Therapeutics raised?
Axon Therapeutics has disclosed $5M raised across 1 round.
Where is Axon Therapeutics headquartered?
Axon Therapeutics is headquartered in San Diego, US.